Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Changchun High-Tech Industry (Group) Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥411 Mil. Changchun High-Tech Industry (Group) Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥-10 Mil.
Changchun High-Tech Industry (Group) Co's interest coverage for the quarter that ended in Jun. 2026 was 40.10.
The higher the ratio, the stronger the company's financial strength is.
SZSE:000661'
s Interest Coverage Range Over the Past 10 Years
Min: 9.42 Med: 150.23 Max: 388.73
Current: 9.42
SZSE:000661's Interest Coverage is ranked worse than 56.87% of 677
companies
in the Drug Manufacturers industry
Industry Median: 12.99
vs SZSE:000661: 9.42
Changchun High-Tech Industry (Group) Co (SZSE:000661) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Changchun High-Tech Industry (Group) Co Interest Coverage Related Terms
Changchun High-Tech Industry (Group) Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Changchun High-Tech Industry (Group) Co Interest Coverage Chart
Changchun High-Tech Industry (Group) Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Changchun High-Tech Industry (Group) Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Changchun High-Tech Industry (Group) Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Changchun High-Tech Industry (Group) Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Changchun High-Tech Industry (Group) Co's Interest Coverage falls into.
Changchun High-Tech Industry (Group) Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changchun High-Tech Industry (Group) Co (SZSE:000661) has a Interest Coverage of 40.10 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Changchun High-Tech Industry (Group) Co and its competitors. This is 73% below median its historical median of 150.23. Over the past decade, Changchun High-Tech Industry (Group) Co's Interest Coverage has ranged from 9.42 to 388.73. According to the industry distribution chart, Changchun High-Tech Industry (Group) Co ranks #385 out of 677 companies in the Drug Manufacturers industry, placing it in the top 56.9%.
Is Changchun High-Tech Industry (Group) Co's Interest Coverage too high?
Changchun High-Tech Industry (Group) Co's current Interest Coverage of 40.10 is 73% below median its 10-year median of 150.23. Over the past 10 years, this metric has ranged from a low of 9.42 to a high of 388.73. The Drug Manufacturers industry median Interest Coverage is 12.99. Changchun High-Tech Industry (Group) Co's value of 40.10 is 208.7% above this industry median. Based on the distribution chart, Changchun High-Tech Industry (Group) Co ranks #385 out of 677 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Changchun High-Tech Industry (Group) Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Changchun High-Tech Industry (Group) Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Changchun High-Tech Industry (Group) Co ranks #385 out of 677 companies for Interest Coverage. This places Changchun High-Tech Industry (Group) Co in the lower half of its industry. The industry median Interest Coverage is 12.99. Changchun High-Tech Industry (Group) Co's value of 40.10 is 208.7% above this benchmark. Historically, Changchun High-Tech Industry (Group) Co's own Interest Coverage has ranged from 9.42 to 388.73 over the past decade. While the company's 10-year median is 150.23 vs. the industry median of 12.99, Changchun High-Tech Industry (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.99, based on 677 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Changchun High-Tech Industry (Group) Co's current Interest Coverage of 40.10 is 208.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Changchun High-Tech Industry (Group) Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Changchun High-Tech Industry (Group) Co's current Interest Coverage is 40.10, which is 73% below median its own 10-year median of 150.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Changchun High-Tech Industry (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co (SZSE:000661) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥85.96, compared to a current price of ¥74.76 — trading 13% below its estimated fair value. The current Interest Coverage is 40.10, which is 73% below median its 10-year median of 150.23 and 208.7% above the Drug Manufacturers industry median of 12.99. Changchun High-Tech Industry (Group) Co's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Changchun High-Tech Industry (Group) Co (SZSE:000661), the current Interest Coverage is 40.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Changchun High-Tech Industry (Group) Co (SZSE:000661) Overvalued in 2026?
Based on GuruFocus' analysis, Changchun High-Tech Industry (Group) Co stock appears to be undervalued.
The current stock price of ¥74.76 is trading 13% below its estimated GF Value™ of ¥85.96.
GuruFocus considers Changchun High-Tech Industry (Group) Co to be Modestly Undervalued.
Key valuation signals for SZSE:000661:
Interest Coverage: 40.10 (73% below median its 10-year median of 150.23)
GF Value™: ¥85.96 vs. price of ¥74.76 (13% below fair value)
Industry Position: 208.7% above the Drug Manufacturers median (#385 of 677)
No single metric tells the full story. See the SZSE:000661 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development. The company operates its business through three segments. The Pharmaceuticals segment focuses on the research and development, manufacturing, and sales of genetically engineered biologics, human vaccines, traditional Chinese medicines, and chemical pharmaceuticals. The Real Estate segment is involved in property development and sales. The Services segment provides scientific research and technical support, along with leasing and various business-related services. It generates the majority of its revenue from the Pharmaceuticals segment.
84GF Score
Get the complete analysis for SZSE:000661
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000661 has been successfully added to your 
